RxDoctor Payments Data

Said Abou Haidar, MD

Psychiatry · Avon Lake, OHNPI 1952487712

Payments from drug & device makers

$19,846in general payments, 2019–2025

Across 1,297 payments — averaging $15.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Lundbeck LLC$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Axsome Therapeutics, Inc.$1K
  • Bausch Health US, LLC$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$975
  • plus $11K from 33 others

What the payments were for

  • Food & beverage$19,62499%
  • Education$2181%
  • Gifts$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,846 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio

Medicare billing

Part B allowed, 2024
$49,710
Medicare patients
113
Services billed
529

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl33$48,353
RexultiBrexpiprazole29$41,871
TrintellixVortioxetine Hydrobromide26$17,630
AuvelityDextromethorphan Hbr/Bupropion13$14,445
Vilazodone Hcl94$7,671
Bupropion XlBupropion Hcl196$5,895
Duloxetine Hcl193$5,439
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine40$3,678
Venlafaxine Hcl ErVenlafaxine Hcl118$3,210
Mirtazapine128$2,908
Clonazepam236$1,972
Lamotrigine107$1,840
Trazodone Hcl174$1,755
Fluoxetine Hcl124$1,600
Desvenlafaxine Succinate ErDesvenlafaxine Succinate30$1,350

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$3,306$48,35333 claims
Otsuka America Pharmaceutical, Inc.Rexulti$900$41,87129 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$1,181$17,63026 claims
Axsome Therapeutics, Inc.Auvelity$1,161$14,44513 claims
Almatica Pharma LLCSertraline Hcl$32$1,120122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,119 psychiatry providers in Ohio.

Other psychiatry in Avon Lake

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →